CCND1 and neoplasm: Since the repression of cyclin D1 promotes cell cycle exit, cellular quiescence and, in some cases, cell differentiation [43] and, in HNSCC tumor models, reduces cell growth and survival [44], these findings indicated that a CCND1 decrease may have a positive impact on patient outcome.